Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients: A Double-Blind Randomized Placebo-Controlled Trial

NCT05944458 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT05944458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients: A Double-Blind Randomized Placebo-Controlled Trial
Lead sponsor
Helwan University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2023
Completion date
June 1, 2025
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antioxidant, critical illness, icu, linezolid, thrombocytopenia